INSPIRE IVF Public Company LimitedSET: IVF🇹🇭 TH

Board Performance · 2025

Prevention of Conflicts of Interest

Has the Company Acted to Prevent Conflicts of Interest?

Yes

Operations in the Past Year

Conflict of Interest Prevention

Conflict of Interest Prevention Policy: The company recognizes the importance of conducting business with integrity, transparency, and accountability, which are principles of good corporate governance and enhance the organization's effectiveness. Therefore, the company has established a policy for directors, executives, and employees to avoid any actions that may conflict with the interests of the company, which may arise from

- Contact with the Company's business associates, such as customers, suppliers, etc.

- Using the Company's internal opportunities or information for personal gain

- Transactions with the Company

- Engaging in businesses that compete with the Company

- etc.

which results in the Company being disadvantaged. In the event that it is unavoidable, the Company will ensure that such transactions are conducted with transparency, fairness, and in the same manner as transactions with unrelated third parties, taking into account the best interests of the Company and fairness to stakeholders. To prevent conflicts of interest, the Company has established the following guidelines:

1. The Company shall not lend or guarantee loans to directors or businesses in which directors hold more than 50% of the shares, unless it is part of the Company's employee welfare and the Company is confident that such actions will not adversely affect the Company.

2. Directors must not engage in businesses that compete with the Company, unless approved by the shareholders' meeting prior to being appointed as a director.

3. Directors, executives, and employees must not use the Company's opportunities or information for their own benefit or for the benefit of others, including engaging in businesses that compete with the Company or engaging in related businesses.

4. Directors, executives, and employees must not attend meetings or abstain from voting on matters in which they have a personal interest that may give rise to a conflict of interest with the Company. If it is necessary to do so for the benefit of the Company, such transactions shall be treated as if they were transactions with an outside party (Arm's Length Basis).

5. Directors, executives, and employees must disclose to the Company any interest they may have in any contracts entered into by the Company.

6. Directors, executives, and employees must prepare and disclose conflicts of interest reports annually or upon the occurrence of an event.

7. Any transactions between directors and the Company that are not ordinary course of business transactions with general commercial terms must be notified to and approved by the Board of Directors and/or shareholders, in accordance with the criteria for connected transactions.

8. The consideration of conflicts of interest and transactions that may involve conflicts of interest must be attended to and considered by independent directors at all times.

9. Directors, executives, and employees of the Company who are aware of inside information shall refrain from using such information for their own benefit or disclosing such information for the benefit of others improperly.

Number of Conflict-of-Interest Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to conflicts of interest (cases)000

Prevention of the Use of Inside Information

Has the Company Acted to Prevent the Use of Inside Information?

Yes

Operations in the Past Year

Using Inside Information for Personal Gain

The Company recognizes the importance and responsibility to its shareholders and stakeholders in accordance with good corporate governance practices. Therefore, to enhance confidence among shareholders, investors, and all stakeholders, the Company has established measures regarding the use of inside information by the Company's personnel, which includes the Board of Directors, executives, including those in accounting and finance positions, those responsible for operations, management, employees, spouses, and unemancipated children of such persons. To ensure equality and fairness in the use of the Company's inside information, the Company prohibits all levels of personnel as mentioned above, including all family members of such personnel who are aware of the Company's inside information, which are material facts affecting the change in the price of securities and which have not been disclosed to the public, from using such information for the purpose of trading in securities or persuading others to buy, sell, offer to buy, or offer to sell the Company's securities, whether by themselves or through an agent, regardless of whether such action is for their own benefit or for the benefit of others. In addition, the Company prohibits such personnel and their family members from disclosing such material facts affecting the change in the price of securities and which have not been disclosed to the public to others for the purpose of enabling such other persons to act as described above for their own benefit.


Insider Trading Policy Details are as follows:

1. The company will provide knowledge to the directors and executives of the company regarding their duties in preparing, disclosing, and submitting reports on the holdings and changes in the holdings of securities and futures contracts of themselves, their spouses, or cohabiting partners, and their minor children, as well as legal entities in which they, their spouses, or cohabiting partners, and their minor children hold shares together exceeding 30 percent of the total voting rights of such legal entities, and such shareholding constitutes the largest proportion in that legal entity, to the Office of the Securities and Exchange Commission in accordance with Section 59 and the penalties under Section 275 of the Securities Act, and the relevant announcements of the Office of the Securities and Exchange Commission, including the reporting of the acquisition or disposal of the company's securities by themselves, their spouses, or cohabiting partners, minor children, and legal entities with the aforementioned characteristics to the Office of the Securities and Exchange Commission in accordance with Section 246 and the penalties under Section 298 of the Securities Act, and the relevant announcements of the Capital Market Supervisory Board.

2. The company's directors and executives are responsible for preparing, disclosing, and submitting reports on their holdings and changes in holdings of the company's securities, as well as their futures contracts, those of their spouses or cohabiting partners, and their minor children, including legal entities in which they hold shares exceeding 30% of the total voting rights of such entities, with the said holdings being the largest proportion in that entity. This must be submitted to the Securities and Exchange Commission in accordance with Section 59 of the Securities and Exchange Act, and a copy of the report must be sent to the company on the same day as the report is submitted to the Securities and Exchange Commission. Furthermore, the preparation, duration, and method of submitting reports on holdings and changes in holdings of securities, as well as the acquisition or disposal of securities, must comply with the criteria set forth in the Securities Act and relevant announcements from the Securities and Exchange Commission. The company secretary will prepare a report to inform the board of directors on a regular quarterly basis.

Number of Inside-Information Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to the use of inside information to seek benefits (cases)000

Anti-Corruption

Has the Company Acted on Anti-Corruption?

Yes

Operations in the Past Year

Anti-Corruption

The Company will conduct its business with an emphasis on anti-corruption, adhering to moral and ethical principles, managing with transparency, and being accountable to all stakeholders. The Company recognizes the importance of not abusing authority, not violating ethical laws, regulations, or Company policies, and not acting or refraining from acting in any manner that may lead others to believe that one holds a position or authority that one does not actually possess. The Company also recognizes the importance of not using one's position or authority to seek undue benefits for oneself or others in various forms, such as soliciting, offering, or giving assets, including other benefits, to government officials or any other person doing business with the Company.

Anti-Corruption Policy In summary:

Policy

1. The Board of Directors, executives, and employees of the Company must not solicit, engage in, or accept corruption in any form, both directly or indirectly, for the benefit of the organization, themselves, their families, friends, and acquaintances, or for the benefit of the business. This covers all businesses in all countries and all relevant departments of the Company. Conducting business with other agencies, whether government agencies, state enterprises, or private companies, both domestically and internationally, must be transparent, fair, and in accordance with the laws of both Thailand and the countries where the Company conducts business.

2. The Company will regularly review compliance with this Anti-Corruption Policy, as well as review practices and procedures to ensure alignment with changes in the business, regulations, and legal requirements. Any violation, support, assistance, or cooperation with corruption will be subject to disciplinary action in accordance with the Company's regulations. In addition, legal penalties may apply if the act is illegal.

Scope and Guidelines

The Company requires that the Board of Directors, executives, and employees at all levels must be cautious of the following forms of corruption:

1. Do not engage in or participate in any form of corruption, both directly and indirectly.

2. Ensure effective communication at all levels, including the Board of Directors, executives, and employees, by requiring that all processes are conducted in strict compliance with the law. If errors occur in the process due to negligence or lack of awareness, penalties will be imposed as prescribed by law.

3. The Board of Directors, executives, and employees of the Company will not engage in or support corruption under any circumstances and will strictly comply with anti-corruption measures.

4. The Board of Directors, executives, and employees of the Company are obligated to report to the Company any acts of corruption related to the Company by notifying their supervisor or responsible person and cooperating in the investigation of the facts.

5. The Company will provide fairness and protection to whistleblowers who report corruption, as well as to individuals who cooperate in reporting and investigating corruption.

6. Those who commit corruption will be subject to disciplinary action in accordance with the Company's regulations and may be subject to legal penalties for such offenses.

7. The Board of Directors, executives, and employees of the Company are responsible for complying with the Good Corporate Governance and Anti-Corruption policies. The Board of Directors assigns the management to communicate and implement anti-corruption measures.

to8. Directors, executives, and employees of the Company are prohibited from soliciting or accepting any property or other benefits for themselves or others that could be construed as an inducement to perform or refrain from performing their duties, or that could cause the Company to lose legitimate benefits. In addition, directors, executives, and employees of the Company are prohibited from giving or offering to give property or other benefits to outside parties to induce such persons to do or refrain from doing anything that is illegal or improper in connection with their position or duties, or in exchange for undue privileges, such as:

- Giving and receiving bribes: Giving or receiving bribes in any form is strictly prohibited in exchange for business favors. Assigning others to give or receive bribes on one's behalf is also prohibited.

- Business relations and procurement with the government: The Company's operations and dealings with the government must be transparent, honest, and conducted in accordance with relevant laws.

- Gifts, entertainment, and other benefits: Giving or receiving gifts, assets, entertainment, or any benefits from customers, partners, or those involved with the Company must be in accordance with the Company's regulations.

- Political contributions: The Company has a policy of not supporting or assisting political parties, political groups, or politicians, either directly or indirectly.

- Donations, charitable contributions, public benefits, and grants or sponsorships: The Company stipulates that donations, charitable contributions, public benefits, and grants or sponsorships must comply with the following requirements:

(1) Must be transparent, lawful, and ethical, and must not be detrimental to society as a whole.

(2) Must not be related to or used as a pretext for bribery.

(3) Must comply with the procedures for reviewing and approving charitable contributions, public benefits, or sponsorships in accordance with the Company's regulations.

(4) In case of any doubt that may have legal implications, seek advice from the legal department in writing. For other matters of significance, it is at the discretion of the management.

9. Create an organizational culture of integrity and adherence to fairness.

10. Provide training to employees within the organization to promote honesty and integrity in their duties and to encourage the adoption of the principles and ethics of the Good Corporate Governance Policy as a practical guideline for the entire organization.

11. Establish human resource management processes that reflect the Company's commitment to anti-corruption measures, from recruitment, training, performance evaluation, compensation, and promotion.

12. Establish disbursement and procurement regulations that specify approval limits, transaction purposes, and recipients, which must be supported by clear documentation. Appropriate levels of authorization should be defined. 13. Conduct internal audits to ensure that the internal control system enables the Company to achieve its objectives, including monitoring the operations of all departments to comply with regulations, rules, and assist in identifying deficiencies and weaknesses, as well as provide recommendations for improving the efficiency and effectiveness of the operating system in accordance with good corporate governance.

14. The Company designates the Company Secretary, the Internal Auditor, or any other person as assigned by the Audit Committee, as appropriate, to be responsible for ensuring the implementation of good corporate governance practices. In 2025, there were no complaints regarding fraudulent or corrupt conduct.

Form of Anti-Corruption Operations

Operation
Communication and training for employees on anti-corruption policy and guidelines

Number of Corruption Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues related to corruption (cases)000

Whistleblowing

Has the Company Implemented Whistleblowing Procedures?

No

Operations in the Past Year

Policy for Receiving Complaints and Reporting Misconduct and Corruption

To ensure that all stakeholders are treated equally and fairly in accordance with the principles of good corporate governance, the company has established channels for reporting tips or complaints indicating that stakeholders have been affected or are at risk of being affected, which could cause harm to all groups of stakeholders due to the company's business operations or the actions of directors, executives, employees, or agents of the company regarding illegal activities or ethical violations, including behaviors that may indicate corruption, unequal treatment, or actions that lack caution and prudence. Tips or complaints regarding such misconduct can be reported as follows.

1. By mail, Chairman of the Board of Directors or Chairman of the Audit Committee, Inspire IVF Public Company Limited, 2nd Floor, Ploenchit Center Building, 5th Floor, Khlong Toei District, Bangkok 10110

2. Email to the Chairman of the Audit Committee, Email ac.commit@inspireivf.com

3. Company website: www.inspireivf.com

4. Suggestion / Comment / Complaint Box within the company

The reporting channel for whistleblowing is a secure avenue that allows whistleblowers to access it with confidence when providing information or tips without the risk of repercussions for the whistleblower in the future. Additionally, it offers guidance on adhering to anti-corruption measures. The company will conduct investigations following established procedures and will document the inquiries in writing while ensuring the confidentiality of the whistleblower's identity. Furthermore, the company will maintain the confidentiality of the complaint data to protect against any potential impact on the whistleblower.

In 2025, no complaints or whistleblowing reports regarding misconduct or fraudulent activities were received.

Number of Whistleblowing Cases

MetricCurrent YearPrevious YearTwo Years Ago
Total number of cases or issues received through whistleblowing channels (cases)000

Selection of Directors & Chief Executives

Are Directors Selected Through the Nomination Committee?

Yes

Are Chief Executives Selected Through the Nomination Committee?

Yes

Number of Directors from Major Shareholders

1

Rights of Minority Shareholders on Director Appointment

Minority shareholders may nominate individuals to serve as directors.

Method of Director Appointment

Method
Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights

Selection of Independent Directors

Criteria for Selecting Independent Directors

Independent directors must possess independence qualifications as prescribed by the Company and in compliance with the regulations of the Stock Exchange of Thailand. In addition, they must be able to attend Board meetings and express their opinions independently. The qualifications of the Company’s independent directors are as follows:

  1. Holding no more than 1% of the total voting shares of the Company*. Such shareholding shall include the shares held by related persons of the independent director.

  2. Not being, or having previously been, an executive director, employee, staff member, salaried advisor, or controlling person of the Company, unless having ceased to have such characteristics for at least two years.

  3. Not being a person related by blood or legal registration to another director, an executive, a major shareholder, a controlling person, or a person nominated to become a director, executive, or controlling person of the Company or its subsidiaries.

  4. Not having, or having previously had, a business relationship with the Company in a manner that may interfere with the exercise of independent judgment, and not being, or having previously been, a significant shareholder or controlling person of any entity having a business relationship with the Company*, unless having ceased to have such characteristics for at least two years.

  5. Not being, or having previously been, an auditor of the Company, and not being a significant shareholder, controlling person, or partner of an audit firm which has the Company’s auditor, unless having ceased to have such characteristics for at least two years.

  6. Not being, or having previously been, any professional service provider, including legal or financial advisor, receiving service fees exceeding Baht 2 million per year from the Company, and not being a significant shareholder, controlling person, or partner of such professional service provider, unless having ceased to have such characteristics for at least two years.

  7. Not being a director appointed as a representative of the Company’s directors, major shareholders, or shareholders who are related to major shareholders.

  8. Not engaging in any business of the same nature and in material competition with the business of the Company or its subsidiaries, nor being a significant partner in a partnership, or an executive director, employee, staff member, salaried advisor, or holding more than 1% of the total voting shares of another company engaging in the same nature of business and in material competition with the Company or its subsidiaries.

  9. Not having any other characteristics that would prevent the independent expression of opinions regarding the Company’s operations.

Did Any Independent Director Have a Business or Professional Relationship?

No

Director Development

Director Development — Introduction

The Company places importance on the continuous development of directors’ knowledge, competencies, and skills to enable them to perform their duties effectively and in alignment with good corporate governance principles. During the year, the Company monitored and proposed relevant training programs, seminars, and knowledge-sharing activities relating to the roles, duties, and responsibilities of directors, including legal and regulatory matters, risk management, and business trends, for directors to consider attending as appropriate.

The Company provides appropriate financial support for participation in such training programs. In addition, where internal training sessions are organized, the Company invites directors to attend in order to enhance their capabilities and broaden their knowledge, beneficial to the Company’s corporate governance on an ongoing basis.

Qualifications for Director Selection — Introduction

  1. Possessing all required qualifications and having none of the prohibited characteristics as prescribed under


    The Public Limited Companies Act B.E. 2535 (1992) (as amended)


    The Securities and Exchange Act B.E. 2551 (2008) (as amended)
    The Company’s Articles of Association and the regulations of the relevant regulatory authorities.

  2. Having knowledge, competence, and experience that are beneficial to the Company’s business.

  3. Being able to fully dedicate sufficient time to perform duties as a director and to consistently attend the Company’s meetings and activities.

  4. Not holding directorship positions in more than five listed companies (in accordance with good corporate governance principles).

  5. Being in good health, actively and constructively participating in meetings, demonstrating the courage to express opinions during meetings, and having a sound work history and ethical record that is recognized by society.

  6. In the case of an independent director, possessing complete qualifications in accordance with the criteria prescribed by the Capital Market Supervisory Board.

Evaluation of Board & Subcommittee Performance

Criteria for Evaluating Board Performance

Organize the evaluation of individual and group assessments of the Board of Directors, including the assessment of subcommittees by groups such as the director's committee structure and qualifications, their roles, duties, responsibilities, and participation in meetings.

Evaluation of Board Performance in the Past Year

The Nomination and Remuneration Committee will provide feedback on the evaluation form to be used for assessing the directors and will present the evaluation form for the board of directors' approval, so that the evaluation form can be utilized and the evaluation results can be presented at the next meeting for the directors' awareness, aimed at enhancing the effectiveness of the directors' performance.

Evaluation Results

Evaluated BodyGroup — Carried Out?Group — Grade / Average ScoreGroup — Grade / Full ScoreIndividual (Self-Assessment) — Carried Out?Individual (Self-Assessment) — Grade / Average ScoreIndividual (Self-Assessment) — Grade / Full ScoreCross (Assessing Other Directors) — Carried Out?
Board Of DirectorY94.92100Y97.32100N
Audit CommitteeY93.97100NN
Other SubcommitteeY99.44100NN
Other SubcommitteeY100100NN

Subcommittees

Subcommittees

Results of the Subcommittee's Duty Performance
  1. Consider establishing a policy for managing the company's transaction risks to cover key risks such as Strategic Risk, Operational Risk, Financial Risk, Policy and Compliance Risk, Image and Reputation Risk, Hazard and Disaster Risk, and other risks such as liquidity risk, epidemic risk, and information technology risk.

  2. Consider and review the approaches and tools for risk management to be effective and appropriate for the nature and size of each aspect of the risks of the transactions that the company undertakes.

  3. Consider and review the setting of risk limits and corrective measures in the event of non-compliance with the specified risk limits.

  4. Monitor the results of risk assessments in both normal and crisis situations.

  5. Assess the risks that may arise from new products or the risks that may arise for newly established businesses, including defining guidelines for preventing risks that may occur with transactions.

  6. Report the company's risk status, guidelines for improvement, and the results of the proceedings to the Board of Directors every quarter.

  7. Perform other duties as assigned by the Board of Directors from time to time.

  1. Consider policies and criteria for recruiting qualified individuals to serve as Directors and the Chief Executive Officer, including the selection and nomination of suitable candidates, as well as re-nomination of retired individuals for such positions, to be proposed to the Board of Directors and/or the Shareholders’ Meeting for appointment.

  2. Review policies and criteria regarding remuneration and benefits for Directors and the Chief Executive Officer.

  3. Provide recommendations to the Board of Directors for approval on the following matters:
    3.1 Recruitment of the Chief Executive Officer, including determination of remuneration and benefits.
    3.2 Remuneration and benefits of Directors, for Board consideration and subsequent submission to the Shareholders’ Meeting for approval.
    3.3 Annual salary adjustments, bonuses, and remuneration of the Chief Executive Officer.

  4. Review and endorse succession planning policies, monitor implementation of succession plans, and provide recommendations on human resource management to the Board of Directors.

Meeting Attendance & Remuneration

Meeting Attendance — Sub-section Introduction

The Annual General Meeting of Shareholders for the year 2025 was held on Thursday, 17 April 2025. Six out of seven directors attended the meeting. Associate Professor Dr. Pornthep Anussornnitisarn, Chairman of the Board of Directors, attended the meeting to inform the attendees of the reason, and assigned Associate Professor Suchart Laopreeda, Chairman of the Audit Committee, to preside over the meeting due to the passing of his father.

Justification for Directors' Non-Attendance

Associate Professor Suchart Laopreeda informed the Company of the reason for his absence from the meeting, stating that he serves as Chairman of the Audit Committee of Inspire IVF Public Company Limited and Equator Solar Capital Company Limited. In order to allow the Board of Directors to express its opinions independently, he abstained from attending the meeting in instances where agenda items involved the consideration of matters relating to Equator Solar Capital Company Limited.

Types of Remuneration of the Board of Directors

The 2025 Annual General Meeting of Shareholders approved the remuneration of the Board of Directors and the sub-committees for 2025 at the same rates as those approved for 2024, as follows:

Board of Directors and Sub-Committees

Meeting Allowance (Baht/person/meeting)

Chairman of the Board

45,000

Chairman of the Audit Committee

20,000

Chairman of the Risk Management Committee

15,000

Chairman of the Nomination and Remuneration Committee

15,000

Director

15,000

Audit Committee Member

15,000

Risk Management Committee Member

10,000

Nomination and Remuneration Committee Member

10,000

Remarks :

  1. Directors who serve as executives/employees are not entitled to receive meeting allowances.

  2. The aggregate amount of remuneration for directors and sub-committee members, including other forms of remuneration such as directors’ bonuses, is capped at not exceeding Baht 2 million.

Remuneration or Benefits Payable to the Board

MetricAmount (Baht)
Remunerations or benefits pending payment to the board of directors over the past year (baht)0

Supervision of Subsidiaries & Associated Companies

Does the Company Have Subsidiaries or Associated Companies?

No

Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?

Yes

Mechanism for Overseeing Management of Subsidiaries

Overseeing the Operations of Subsidiaries and Associated Companies

The Inspire IVF Public Company Limited has a policy for overseeing the operations of its subsidiaries and joint ventures. Therefore, the nomination and exercise of voting rights for the appointment of individuals as directors in subsidiaries and joint ventures (specifically for the directors of joint ventures representing the company) must be approved by the company's board of directors in advance. The individuals appointed as directors in subsidiaries or joint ventures are required to act in the best interests of those subsidiaries or joint ventures (not in the best interests of the company). Furthermore, the company stipulates that the appointed individuals must obtain approval from the board of directors before voting or exercising voting rights on significant matters of the subsidiaries and joint ventures, which are of equal importance to matters that would require prior approval from the board of directors if conducted by the company itself. The appointment of representatives as directors in the subsidiaries and joint ventures shall be in accordance with the shareholding proportions of the company and/or the agreements among the shareholders in the aforementioned subsidiaries and joint ventures.

Furthermore, in the case of a subsidiary, the company stipulates that individuals appointed by the company must ensure that the subsidiary conducts transactions related to interconnected matters, the acquisition or disposal of assets, or any other significant transactions of the subsidiary completely and accurately according to the regulations of the Securities and Exchange Commission and/or the Stock Exchange of Thailand, and apply the relevant criteria for disclosure and the aforementioned transactions in the same manner as the company's criteria, including overseeing the collection and recording of the subsidiary's accounting data so that the company can verify and compile it to prepare consolidated financial statements in accordance with the deadlines set by the Stock Exchange of Thailand.

As of 31 December 2025, the Company had one subsidiary, namely M22 Company Limited, with a registered capital of Baht 1,000,000.

Oversight Mechanisms

Mechanism
Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings
Transactions between the Company and related persons
Acquisition or disposal of assets

Board Duty Performance — Overview

Board Duty Performance — Overall Description

Recruitment, Development, and Performance Evaluation of the Board of Directors

The Company recognizes the importance of recruiting and appointing qualified directors to serve on the Board of Directors. The selection process must meet the criteria of the Nomination and Remuneration Committee, which will consider the qualifications criteria under Section 68 of the Public Limited Company Act B.E. 2535 (1992) and the Notification of the Capital Market Supervisory Board Tor Chor. 39/2559 (2016) Re: Application for and Permission to Offer Newly Issued Shares and/or relevant laws. The candidates must not possess any prohibited characteristics as specified in the Notification of the Board of Governors of the Stock Exchange of Thailand Kor Jor. 8/2553 (2010) Re: Determination of Disqualifying Characteristics of Directors and Executives of Listed Companies (as amended). They must also have the knowledge, abilities, and work experience appropriate for the Company's business. The Nomination and Remuneration Committee will consider the persons to be appointed as directors, both directors and independent directors. The composition, qualifications, and appointment of directors are in accordance with the regulations approved by the Board of Directors' meeting, as follows:

1. Board of Directors

Composition

(1) The Board of Directors shall consist of not less than 5 directors, at least half of whom must reside in Thailand.

(2) The Board of Directors shall consist of at least one-third (1/3) independent directors, but not less than 3 persons. Independent directors must be independent from the control of management and major shareholders, and must not have any financial or managerial involvement or interest in the Company. They must also meet the qualifications for independent directors as prescribed by the SEC or the SET.

(3) The Board of Directors shall elect one independent director as the Chairman of the Board of Directors. If the Board of Directors deems it appropriate, it may elect one or more directors as Vice Chairman of the Board of Directors. The Vice Chairman of the Board of Directors shall have such duties as may be assigned by the Chairman of the Board of Directors or as otherwise prescribed.

(4) The Chief Executive Officer is appointed as a member of the Board of Directors by virtue of his/her position, and the Company has a policy that the Chairman of the Board of Directors shall be a different person from the Chief Executive Officer in order to ensure checks and balances in the work of the management and to clearly separate the roles, duties, and responsibilities of the Chairman of the Board and the Chief Executive Officer. Upon the appointment of a new director, the Company will provide an orientation for the new director and provide the Board Charter, the latest annual report, the Good Corporate Governance Manual, the Code of Conduct and Business Ethics, and the Company's Anti-Corruption Policy to ensure that they are aware of the Company's information necessary for the performance of their duties as directors of the Company.

Qualifications

Directors of the Company must have the following qualifications:

(1) Directors must be knowledgeable, capable, and experienced in corporate management. They must be honest, have business ethics, and have sufficient time to devote their knowledge, abilities, and duties to the Company. They must also possess other qualifications as specified in the Company's Articles of Association.

(2) Have the qualifications and not possess any prohibited characteristics for holding the position of director as prescribed by the Public Limited Company Act, the Securities and Exchange Act, and other relevant laws, or as prescribed by the SEC. In addition, they must not possess any characteristics that indicate a lack of suitability to be entrusted with the management of a business in which the public holds shares, as prescribed by the SEC.

(3) Company directors may hold directorships in other companies, provided that such directorships do not interfere with the performance of their duties as directors of the Company and are in accordance with the guidelines of the Securities and Exchange Commission ("SEC") and the Stock Exchange of Thailand ("SET"). In holding directorships in other listed companies, the total number of directorships, including those in the Company, must not exceed 5 companies.

(4) Directors shall not engage in any business which is of the same nature and competes with the business of the Company, or become a shareholder in a general partnership, or an unlimited liability partner in a limited partnership, or a director in another company which carries on a business of the same nature and competes with the business of the Company, whether for their own benefit or for the benefit of others, unless such director has notified the shareholders' meeting prior to the resolution appointing such director.

(5) Independent directors must meet the independence qualifications as prescribed by the Company and in accordance with the Notification of the Stock Exchange of Thailand Re: Qualifications and Scope of Work of the Audit Committee. They must be able to safeguard the interests of all shareholders equally and avoid conflicts of interest. In addition, they must be able to attend Board meetings and express their opinions independently. The qualifications of the Company's independent directors are as follows:

5.1) Holds not more than 1 percent of the total voting shares of the Company. For this purpose, the shareholding of the related persons of such independent director shall also be included.

5.2) Not be or have ever been a director, executive, employee, regular salaried consultant, or controlling person of the Company, unless such status has ceased for at least 2 years.

5.3) Not be a person who has a relationship by blood or registration under the law with other directors, executives of the Company, major shareholders, controlling persons, or persons to be proposed as directors, executives, or controlling persons of the Company or its subsidiaries.

5.4) Not have or have ever had a business relationship with the Company that could interfere with the independent judgment of the person, including not being or having ever been a material shareholder or controlling person of a person who has a business relationship with the Company, unless such status has ceased for at least 2 years.

5.5) Not be or have ever been an auditor of the Company, and not be a material shareholder, controlling person, or partner of an audit firm that audits the Company, unless such status has ceased for at least 2 years.

5.6) Not be or have ever been a professional service provider, including legal or financial advisors, who receives a fee of more than 2 million baht per year from the Company, and not be a material shareholder, controlling person, or partner of such professional service provider, unless such status has ceased for at least 2 years.

5.7) Not be a director appointed to represent a director of the Company, a major shareholder, or a shareholder who is a related person of a major shareholder.

5.8) Not engage in any business that is the same as or materially competes with the business of the Company or its subsidiaries, or be a material partner in a partnership, or be a director, executive, employee, regular salaried consultant, or hold more than 1 percent of the total voting shares of another company that engages in any business that is the same as or materially competes with the business of the Company or its subsidiaries.

5.9) Have no other characteristics that would prevent them from providing independent opinions on the Company's operations.

Term of Office

(1) At each Annual General Meeting of Shareholders, at least one-third (1/3) of the directors shall retire from office. If the number of directors is not divisible by three, the number of directors retiring shall be the number nearest to one-third (1/3). The directors to retire in the first and second years after the registration of the Company shall be determined by drawing lots. In subsequent years, the directors who have been in office the longest shall retire. Directors who retire by rotation may be re-elected.

(2) In addition to the expiration of their term, directors shall vacate office upon:

a. Death

b. Resignation

c. Lacks the qualifications or possesses any prohibited characteristics for holding the position of director under the Public Limited Company Act and/or the Securities and Exchange Act.

d. The shareholders' meeting resolves to remove the director by a vote of not less than 3 out of 4 of the total votes of the shareholders present and entitled to vote, representing not less than one-half of the total number of shares held by the shareholders present and entitled to vote.

e. Court order for removal

(3) Any director wishing to resign shall submit a letter of resignation to the Company. The resignation shall take effect from the date the letter of resignation reaches the Company.

(4) In the event that a vacancy on the Board of Directors occurs for any reason other than the expiration of the term, the Board of Directors shall elect a person who is qualified and not disqualified under the Company's Articles of Association to fill the vacancy at the next meeting of the Board of Directors, unless the remaining term of office of the vacating director is less than 2 months. The person so elected shall hold office only for the unexpired term of the vacating director. The resolution of the Board of Directors in this case must be passed by a vote of not less than 3 out of 4 of the remaining directors.

(5) The election of directors shall be in accordance with the Company's Articles of Association and relevant laws. The process of recruiting directors must be transparent and clear. The Nomination and Remuneration Committee will be responsible for considering the suitability of the persons nominated to serve as directors by considering their educational background, professional experience, qualifications, and the absence of prohibited characteristics, for the benefit of the Board of Directors and shareholders in making their decisions.

2. Audit Committee

Composition

(1) The Audit Committee shall consist of at least 3 independent directors appointed by the Board of Directors or the shareholders' meeting of the Company (as the case may be).

(2) The Board of Directors or the shareholders' meeting of the Company (as the case may be) shall appoint 1 Audit Committee member to serve as the Chairman of the Audit Committee.

(3) In the event that a vacancy on the Audit Committee occurs due to the expiration of the term or any other reason that renders an Audit Committee member unable to serve until the end of his/her term, the Board of Directors or the shareholders' meeting (as the case may be) shall appoint a qualified person to fill the vacancy immediately, or within 3 months from the date the vacancy occurs, in order to ensure the continuity of the Audit Committee's work at all times.

Qualifications

(1) Have the qualifications of an independent director as prescribed by the Securities and Exchange Act, including the notifications of the Capital Market Supervisory Board and the requirements of the SET.

(2) Not be a director who has been authorized by the Board of Directors to make decisions in the operation of the Company, its parent company, subsidiaries, affiliates, major shareholders, or controlling persons of the Company.

(3) Not be a director of a parent company, subsidiary, or affiliate that is a listed company.

(4) Have sufficient knowledge and experience to perform their duties as Audit Committee members in accordance with the assigned tasks.

(5) Not be a director in more than 5 other listed companies.

(6) At least 1 Audit Committee member shall have adequate knowledge and experience in accounting or finance and be able to review the reliability of the financial statements.

(7) Receive continuous and regular training and knowledge enhancement in matters related to the Audit Committee's operations to keep abreast of potential changes and to enhance their knowledge of the Company's operations on an ongoing basis to enhance the effectiveness of the Audit Committee.

(8) Be able to devote sufficient time and consideration to the performance of their duties as Audit Committee members.

Term of Office

(1) The term of office of the Audit Committee members shall be the same as the term of office of the directors of the Company.

(2) An Audit Committee member whose term expires may be reappointed for another term.

(3) The terms of office of each Audit Committee member shall expire on different dates to ensure the benefit and continuity of the Audit Committee's work.

3. Executive Committee

Composition

(1) The Executive Committee shall consist of not less than 5 directors (who are not independent directors) and/or executives of the Company (who are not directors) appointed by the Board of Directors.

(2) The Executive Committee shall elect 1 Executive Committee member to serve as the Chairman of the Executive Committee. The Chairman of the Executive Committee may be the same person as the Chief Executive Officer.

(3) The Executive Committee has the authority to appoint a person deemed appropriate by the Executive Committee to act as secretary to the Executive Committee to assist the Executive Committee in its operations relating to the scheduling of meetings, preparation of meeting agendas, distribution of meeting materials, recording of meeting minutes, and other tasks as assigned by the Executive Committee.

Qualifications of the Executive Committee

(1) Be a director (who is not an independent director) or an executive of the Company (who is not a director) who has knowledge, ability, and experience beneficial to the management of the organization, is honest, has business ethics, and has sufficient time to devote their knowledge, abilities, and duties to the Company.

(2) Have the qualifications and not possess any prohibited characteristics for holding the position of director as prescribed by the Public Limited Company Act, the Securities and Exchange Act, and other relevant laws, or as prescribed by the SEC. In addition, they must not possess any characteristics that indicate a lack of suitability to be entrusted with the management of a business in which the public holds shares, as prescribed by the SEC.

Term of Office

(1) Executive Committee members shall vacate office upon:

a) The Board of Directors resolves to remove the director from office.

b) Death

c) Resignation, by submitting a letter of resignation to the Company. The resignation shall take effect from the date the letter of resignation reaches the Company.

d) Ceases to be a director and/or executive of the Company.

4. Nomination and Remuneration Committee

Composition

(1) The Nomination and Remuneration Committee shall consist of at least 3 directors of the Company, a majority of whom shall be independent directors.

(2) The Chairman of the Nomination and Remuneration Committee must be an independent director.

(3) The Nomination and Remuneration Committee may appoint a secretary to the Nomination and Remuneration Committee to assist the Nomination and Remuneration Committee in its operations relating to the scheduling of meetings, preparation of meeting agendas, distribution of meeting materials, recording of meeting minutes, and preparation of meeting reports.

Term of Office

(1) The term of office of the Nomination and Remuneration Committee members shall be the same as the term of office of the directors of the Company.

(2) A Nomination and Remuneration Committee member whose term has expired may be reappointed for another term.

(3) In addition to the expiration of the term, the Nomination and Remuneration Committee members shall vacate office upon:

a. Death

b. Resignation

c. Lacks the qualifications or possesses any prohibited characteristics for holding the position of director of the Company under the Public Limited Company Act and/or the Securities and Exchange Act (if serving as a director of the Company).

d. The Board of Directors resolves to remove the director from office.

5. Risk Management Committee

Composition

(1) The Risk Management Committee is appointed by the Board of Directors or the shareholders' meeting (as the case may be) and consists of not less than 3 directors, at least 1 of whom must be an independent director. The Board of Directors or the shareholders' meeting (as the case may be) shall appoint 1 director to serve as the Chairman of the Risk Management Committee.

(2) The Risk Management Committee shall appoint a secretary to the Risk Management Committee from among persons deemed appropriate by the Risk Management Committee to assist the Risk Management Committee in its operations relating to the scheduling of meetings, preparation of meeting agendas, distribution of meeting materials, recording of meeting minutes, and preparation of meeting reports.

Term of Office

(1) The term of office of the Risk Management Committee shall be the same as the term of office of the Board of Directors. Members of the Risk Management Committee whose term expires may be reappointed for another term.

(2) Risk Management Committee members shall vacate office for the following reasons:

a) Ceases to be a director and/or employee of the Company.

b) Completion of the term of office, unless reappointed for another term.

c) Death

d) Resignation, by submitting a letter of resignation to the Company. The resignation shall take effect from the date the letter of resignation reaches the Company.

e) The Board of Directors resolves to remove the director from office.

6. Chief Executive Officer

The Board of Directors shall ensure that the Chief Executive Officer is recruited and developed to have the knowledge, skills, experience, and qualifications necessary to drive the organization towards its goals.

(1) The Board of Directors will consider or assign the Nomination and Remuneration Committee to consider the policies and criteria for recruiting qualified persons to serve as Chief Executive Officer, including the selection and nomination of qualified persons, including the nomination of retired persons to return to such positions, for presentation to the Board of Directors' meeting and/or the shareholders' meeting for appointment.

(2) The Board of Directors will consider or assign the Nomination and Remuneration Committee to review the policies and criteria for determining the remuneration and benefits of the Chief Executive Officer.

Succession Planning

The Company has a policy of proactive human resource preparedness to prevent future shortages of personnel in key positions within the organization. The Company has a succession plan in place to ensure continuity of operations and management.

The Board of Directors has approved the Succession Planning for executive positions that require succession planning, including the Chief Executive Officer, Chief Medical Officer, Chief Embryology Officer, Chief Operating Officer, and Chief Financial Officer. The qualifications required for each position have been defined, taking into consideration the nature of the work, responsibilities of the position, and the expectations of the organization, in order to provide opportunities for potential and capability development and to become successors to key positions.


T

Training Category

Course Title

Orientation for New Directors / New Employees

Good Corporate Governance or Others

Functional / Job-Related Training

Occupational Health, Safety, and Environment

- Orientation Program for New Directors / New Employees

- Personal Data Protection Act (PDPA) Course

- ESG Risk Management: Navigating Climate Risks

- 31st TSRM 2025

- 32nd TSRM 2025

- Intrauterine Insemination (IUI)

- 18th ATE Conference

- e-Learning CFO Refresher

- The 17th Reproductive Medicine Training Course 2025

- Basic Firefighting and Fire Evacuation Drill (Simulation-Based)

- First Aid – CPR and Use of AED

- Basic Firefighting and Fire Evacuation Drill (Simulation-Based)

Development

The Company provides orientation and fundamental organizational knowledge to newly appointed directors to ensure their understanding of the Company’s business, roles, and responsibilities. The Company also promotes the continuous development of directors’ knowledge and competencies across all relevant areas to enable them to perform their duties effectively in response to changing external circumstances and to support the Company’s sustainable development.

During the years 2021–2025, the Company supported directors in attending the following training programs:

  • Director Accreditation Program (DAP)

  • Advanced Audit Committee Program (AACP)

  • Financial Statements for Directors (FSD)

Board Performance Evaluation

At the end of each year, the Board of Directors will evaluate its overall performance and the performance of each director. The evaluation scores of the Board of Directors, including the subcommittees, will be reported to the Board of Directors. The performance evaluation form for the Board of Directors and subcommittees will be reviewed annually. The directors' comments will be used to improve the performance of the Board of Directors to enhance the effectiveness of the Board of Directors.


Meeting Attendance

All directors attended every Board meeting, except for agenda items in which they had a conflict of interest.


Supervision of Subsidiaries and Associated Companies

To enable Inspire IVF Public Company Limited to expand its business for stable and sustainable growth in the long term, by being able to control and manage the business and operations of its subsidiaries as if they were one of its own units and/or to effectively monitor the business operations of its associated companies, the Company has established this policy on investment in and supervision over the operations of subsidiaries and associated companies.

Investment

The Company has a policy to invest in subsidiaries and associated companies that have the potential to grow and generate good returns on investment, which may be businesses that support the Company's core business or other businesses with a promising future. Such investments must be appropriate to the business conditions, the Company's strategic plan, and the rules and regulations of the regulatory authorities.

The Company will focus on long-term investments by considering the fundamentals and prospects of the businesses in which it invests, and will invest in appropriate proportions to enable it to participate in the management and direction of the subsidiaries and associated companies, as well as to promote the sustainable growth of the businesses in which it invests.

The Company will consider investments carefully and prudently by analyzing the feasibility of the proposed investment plan, taking into account the risks, returns, the Company's financial liquidity, and the country's economic conditions. The investment plan will be submitted to the Board of Directors for approval. The Company will establish a system to control, monitor, and report on investments to the Board of Directors regularly.

Supervision of Subsidiaries and Associated Companies

Inspire IVF Public Company Limited has a policy to supervise the operations of its subsidiaries and associated companies. Therefore, the nomination and exercise of voting rights in the appointment of directors of subsidiaries and associated companies (only for directors of associated companies representing the Company) must be approved by the Board of Directors. Persons appointed as directors of subsidiaries or associated companies have a duty to act in the best interests of such subsidiaries or associated companies (not in the best interests of the Company). The Company has stipulated that such appointed persons must obtain the approval of the Board of Directors before voting or exercising their voting rights on material matters of the subsidiaries and associated companies that are of the same significance as those that would require the approval of the Board of Directors if they were to be carried out by the Company itself. The appointment of representatives to serve as directors of subsidiaries and associated companies shall be in accordance with the Company's shareholding proportion and/or the shareholders' agreement of such subsidiaries and associated companies.

In addition, in the case of subsidiaries, the Company requires that the persons appointed by the Company ensure that the subsidiaries make complete and accurate disclosures of related party transactions, the acquisition or disposal of assets, or any other material transactions of such subsidiaries in accordance with the regulations of the SEC and/or the SET, and apply the same principles relating to disclosure and the aforementioned transactions as those applicable to the Company. The Company also requires that the appointed persons ensure that the subsidiaries maintain their accounting records and information in a manner that enables the Company to inspect and consolidate such information in order to prepare consolidated financial statements in a timely manner as required by the SET.

As of December 31, 2023, the Company has no subsidiaries and/or associated companies.


Monitoring Compliance with Corporate Governance Policies and Practices

At the Board of Directors’ Meeting No. 6/2025 held on 11 November 2025, the Board reviewed policies related to monitoring compliance with the Company’s corporate governance policies and practices, as follows:

- Prevention of conflicts of interest

- Prevention of the use of inside information for personal gain

- Anti-corruption

- Whistleblowing

Audit Committee Duty Performance

Results of the Audit Committee's Duty Performance in the Past Year

1. Financial Statements

a. Review to ensure that the Company and its subsidiaries have a process for preparing and disclosing information in the Company's financial statements that is accurate, complete, adequate, reliable, and timely by coordinating with the auditors and executives responsible for preparing both quarterly and annual financial statements.

b. If necessary, for the benefit of considering opinions on various actions of the Company, the Audit Committee may seek independent opinions from other professional advisors, with the Company being responsible for the expenses incurred.

2. Connected Transactions and Transactions that May Involve Conflicts of Interest

a. Consider connected transactions and transactions that may involve conflicts of interest in accordance with the law and the regulations of the Stock Exchange of Thailand to ensure that such transactions are reasonable and in the best interests of the Company.

b. Consider the Company's disclosure of information in the event of a connected transaction or a related transaction or a transaction that may give rise to a conflict of interest to ensure that it is accurate and complete.

3. Internal Control

a. Review to ensure that the Company has adequate and effective internal controls and an internal audit system, including a review of transactions that may result in financial statement fraud.

b. Consider the audit results and recommendations of the auditors and the internal audit department regarding the internal control system and propose to the management to improve and correct them according to the recommendations, as well as follow up on the implementation of such recommendations.

c. Consider the independence of the internal audit unit and provide an opinion on the consideration, appointment, transfer, and termination of the head of internal audit.

d. Review and evaluate the annual internal audit plan to ensure it is appropriate to the type and level of risk of the Company.

f. Review the independence of the internal auditor in accessing information necessary for internal audit work.

e. Review the report from the internal audit unit on the assessment of the effectiveness of the internal control system and discuss with the internal audit unit the observations in such report.

4. Auditor

a. Consider, select, propose the appointment of, and propose compensation for the auditor to obtain an independent auditor, taking into account credibility, adequacy of resources, the audit workload of the audit firm, and the experience of the personnel assigned to audit the Company, including performance in the past year, as well as consider the removal of the auditor.

b. Meet with the auditor at least quarterly to discuss issues found or observed by the auditor from the audit/review of the financial statements.

c. Meet privately with the Company's auditors without management present at least once a year, with such agenda item being one of the first items on the meeting agenda. Upon completion of the agenda item, other agenda items may be discussed, which are items that require the invitation of management to participate.

d. Review the auditor's report submitted to the management for improvement and follow up on the implementation of such recommendations.

5. Review the Company's compliance with the Securities and Exchange Act.

a. SET regulations and laws related to the Company's business, as well as the Company's Code of Conduct.

b. Investigate the facts regarding any suspicious circumstances reported by the auditor regarding fraud or violation of laws related to the performance of duties of directors and executives and report the preliminary investigation results to the SEC Office.

6. Supervision of Anti-Fraud and Corruption Measures

a. Supervise the internal control process, accounting and financial reporting system, internal audit system, risk management, and other departments related to the Anti-Fraud and Corruption Policy to ensure that the performance evaluation of the Board of Directors ensures that the various processes are appropriately defined, fully implemented, and effective.

b. Supervise the process of receiving whistleblowing reports in the event that employees and stakeholders have doubts or witness suspicious acts that violate or fail to comply with laws, regulations, rules, ethics, or corporate governance policies to assure whistleblowers that the Company has an independent investigation process and appropriate follow-up procedures.

7. Other Responsibilities

a. Perform other duties as assigned by the Board of Directors.

b. Have duties as further prescribed by the Stock Exchange of Thailand (SET).

c. Review the Charter annually to consider the responsibilities of the Audit Committee and propose changes if necessary.

Executive Committee Duty Performance

Results of the Executive Committee's Duty Performance in the Past Year

  1. Review and screen proposals from the Chief Executive Officer, and present business goals, policies, business plans, and the Company’s annual budget to the Board of Directors for approval.

  2. Supervise, oversee, and monitor the Company’s operations to ensure compliance with approved policies, goals, business strategies, budgets, and other authorities granted by the Board of Directors, ensuring efficiency and effectiveness, while providing consultation and guidance to senior management.

  3. Monitor the performance and progress of investment projects in each business, and report results, issues, and improvement measures to the Executive Committee.

  4. Approve normal business transactions such as investments, in accordance with the approved investment budget and authority matrix endorsed by the Board of Directors.

  5. Consider the Company’s profit and loss, and propose interim or annual dividend payments for Board approval.

  6. Present an organizational structure appropriate to the Company’s operations for Board approval.

  7. Facilitate participation of executives, management, or employees in Executive Committee meetings, and ensure provision of relevant information for discussion.

  8. Engage advisors or independent experts to provide opinions or recommendations as necessary.

  9. Appoint and/or delegate authority to one or more Executive Directors or other persons to perform specific actions under the Committee’s supervision, with authority as deemed appropriate and within specified timeframes. Such delegation must not constitute sub-delegation that allows approval of transactions involving conflicts of interest, unless already approved by the Board or conducted under normal business conditions in compliance with regulations of the Capital Market Supervisory Board, the Stock Exchange of Thailand, or other relevant authorities.

Contents